Stifel Maintains Buy on Alamar Biosciences, Raises Price Target to $32
Stifel analyst Daniel Arias maintains Alamar Biosciences (NASDAQ: ALMR ) with a Buy and raises the price target from $28 to $32.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.